Of over 350,000 adults with type 2 diabetes, thyroid cancer risk was significantly higher within the first year after GLP-1 agonist initiation compared with SGLT2 inhibitors, DPP-4 inhibitors ...
Thyroid cancer continues to be overdiagnosed, though the survival rate remains unchanged, according to a study published Feb. 5 in The Lancet Diabetes & Endocrinology. Here are five notes from the ...
In the largest study of its kind involving a diabetic population, the use of glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs shows no significantly increased risk for thyroid cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback